{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:49:26Z","timestamp":1790041766040,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006143","name":"Department of Science and Technology, Government of Kerala","doi-asserted-by":"publisher","award":["SR\/S1\/OC-33\/2008"],"award-info":[{"award-number":["SR\/S1\/OC-33\/2008"]}],"id":[{"id":"10.13039\/501100006143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111601","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:59:14Z","timestamp":1565315954000},"page":"111601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5113-6627","authenticated-orcid":false,"given":"Raj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirjhar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyank","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev K.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2877-1590","authenticated-orcid":false,"given":"Kapileswar","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vachan S.","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khyati","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam C.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-6293","authenticated-orcid":false,"given":"Asit K.","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111601_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fmed.2018.00316","article-title":"Inflammation\u2013Nature's way to efficiently respond to all types of challenges: implications for understanding and managing \u201cthe epidemic\u201d of chronic diseases","volume":"5","author":"Bennett","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2019.111601_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111601_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2014present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2019.111601_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","article-title":"Atherosclerosis in rheumatoid arthritis: is it all about inflammation?","volume":"11","author":"Skeoch","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejmech.2019.111601_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/jdv.15339","article-title":"Severity, heterogeneity and systemic inflammation in psoriasis","volume":"33","author":"Christophers","year":"2019","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejmech.2019.111601_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111601_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10555-006-9016-0","article-title":"Inflammation and disease progression","volume":"25","author":"Krishnamoorthy","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2019.111601_bib8","first-page":"1","article-title":"How prevalent is chronic pain, Pain","volume":"11","author":"Harstall","year":"2003","journal-title":"Clin. Update"},{"key":"10.1016\/j.ejmech.2019.111601_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1871530317666171114122417","article-title":"A\u00a0clinical update and global economic burden of rheumatoid arthritis","volume":"18","author":"Fazal","year":"2018","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2019.111601_bib10","series-title":"Chronic Inflammation","author":"Pahwa","year":"2018"},{"key":"10.1016\/j.ejmech.2019.111601_bib11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2019.111601_bib12","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.111601_bib13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(02)07922-9","article-title":"Fatal allergic vasculitis associated with celecoxib","volume":"359","author":"Schneider","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.111601_bib14","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1021\/jm0402059","article-title":"Adverse cardiovascular effects of the coxibs","volume":"48","author":"Dogn\u00e9","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib15","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMp0908913","article-title":"A\u00a0difficult balance\u2014pain management, drug safety, and the FDA","volume":"361","author":"Woodcock","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.111601_bib16","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2174\/138945011795677764","article-title":"Biology of Cox-2: an application in cancer therapeutics","volume":"12","author":"Khan","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2019.111601_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0269881112467089","article-title":"A\u00a0review of anti-inflammatory agents for symptoms of schizophrenia","volume":"27","author":"Keller","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.ejmech.2019.111601_bib18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"M\u00fcller","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejmech.2019.111601_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yebeh.2014.12.032","article-title":"Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment","volume":"44","author":"Katyal","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejmech.2019.111601_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","article-title":"The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes","volume":"49","author":"Niranjan","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.111601_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd1929","article-title":"COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs","volume":"5","author":"Mitchell","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111601_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2013.07.017","article-title":"Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms","volume":"719","author":"Van Dam","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111601_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2567.2002.01403.x","article-title":"The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis","volume":"106","author":"Rangel Moreno","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.ejmech.2019.111601_bib24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/092986710790979980","article-title":"Progress in COX-2 inhibitors: a journey so far","volume":"17","author":"Chakraborti","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/ml400500e","article-title":"2-(2-Arylphenyl) benzoxazole as a novel anti-inflammatory scaffold: synthesis and biological evaluation","volume":"5","author":"Seth","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111601_bib26","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1055\/s-2001-17519","article-title":"Synthesis of rofecoxib,(MK 0966, Vioxx\u00ae 4-(4\u2032-methylsulfonylphenyl)-3-phenyl-2 (5H)-Furanone), a selective and orally active inhibitor of cyclooxygenase-2","author":"Therien","year":"2001","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.111601_bib27","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.bmcl.2004.02.099","article-title":"Simple aromatic compounds containing propenone moiety show considerable dual COX\/5-LOX inhibitory activities","volume":"14","author":"Jahng","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111601_bib28","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/jm0510474","article-title":"Synthesis and structure\u2212 activity relationship studies of 1, 3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases","volume":"49","author":"Praveen Rao","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib29","first-page":"7044","article-title":"Synthesis and biological evaluation of 1, 3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1\/-2 inhibitors, Bioorg","volume":"14","author":"Zarghi","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2009.12.004","article-title":"Anti-inflammatory and immunosuppressive effects of the enaminone E121","volume":"632","author":"El-Hashim","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111601_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168567","article-title":"Anti-inflammatory properties of the enaminone E121 in the dextran sulfate sodium (DSS) colitis model","volume":"11","author":"Khajah","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111601_bib32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.lfs.2011.07.007","article-title":"Anti-tussive and bronchodilator mechanisms of action for the enaminone E121","volume":"89","author":"El-Hashim","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2019.111601_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/jphp.12811","article-title":"Current and novel anti-inflammatory drug targets for inhibition of cytokines and leucocyte recruitment in rheumatic diseases","volume":"70","author":"Szollosi","year":"2018","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111601_bib34","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1016\/S0040-4020(03)01201-8","article-title":"Recent developments in the chemistry of enaminones","volume":"59","author":"Elassar","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2019.111601_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1359-6446(04)03298-2","article-title":"Timely synthetic support for medicinal chemists","volume":"10","author":"Potoski","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.111601_bib36","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1021\/jm200187y","article-title":"The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates","volume":"54","author":"Roughley","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1351\/pac200072071207","article-title":"Synthetic pathways and processes in green chemistry. Introductory overview","volume":"72","author":"Tundo","year":"2000","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcata.2005.09.021","article-title":"A\u00a0remarkably rapid regioselective synthesis of \u03b2-enaminones using silica chloride in a heterogeneous as well as an ionic liquid in a homogeneous medium at room temperature","volume":"245","author":"Gholap","year":"2006","journal-title":"J.\u00a0Mol. Catal. A Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1039\/cs9770600277","volume":"6","author":"Greenhill","year":"1977","journal-title":"Enaminones, Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2019.111601_bib40","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1016\/j.tetlet.2004.08.097","article-title":"Magnesium perchlorate as an efficient catalyst for the synthesis of imines and phenylhydrazones","volume":"45","author":"Chakraborti","year":"2004","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111601_bib41","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1021\/jo062140i","article-title":"An extremely efficient three-component reaction of aldehydes\/ketones, amines, and phosphites (Kabachnik\u2212 Fields reaction) for the synthesis of \u03b1-aminophosphonates catalyzed by magnesium perchlorate","volume":"72","author":"Bhagat","year":"2007","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib42","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1021\/jo8009006","article-title":"Zirconium (IV) compounds as efficient catalysts for synthesis of \u03b1-aminophosphonates","volume":"73","author":"Bhagat","year":"2008","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-2860(87)85074-3","article-title":"\u03b2-diketone interactions: Part 5. Solvent effects on the keto\u21cb enol equilibrium","volume":"161","author":"Emsley","year":"1987","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2019.111601_bib44","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hlca.194402701134","article-title":"Bestimmung von Keto-Enol-Gleichgewichten in wasser","volume":"27","author":"Schwarzenbach","year":"1944","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2019.111601_bib45","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1021\/jo0163039","article-title":"Influence of hydrogen bonding in the activation of nucleophiles: PhSH\u2212(catalytic) KF in N-methyl-2-pyrrolidone as an efficient protocol for selective cleavage of alkyl\/aryl esters and aryl alkyl ethers under nonhydrolytic and neutral conditions","volume":"67","author":"Chakraborti","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib46","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1021\/jo0256540","article-title":"Demand-based thiolate anion generation under virtually neutral conditions: influence of steric and electronic factors on chemo-and regioselective cleavage of aryl alkyl ethers","volume":"67","author":"Chakraborti","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib47","series-title":"Solvents and Solvent Effects in Organic Chemistry","author":"Reichardt","year":"2011"},{"key":"10.1016\/j.ejmech.2019.111601_bib49","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1039\/b710414f","article-title":"\u201cOn water\u201d organic synthesis: a highly efficient and clean synthesis of 2-aryl\/heteroaryl\/styryl benzothiazoles and 2-alkyl\/aryl alkyl benzothiazolines","volume":"9","author":"Chakraborti","year":"2007","journal-title":"Green Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib50","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1021\/ol0611191","article-title":"Catalyst-free chemoselective N-tert-butyloxycarbonylation of amines in water","volume":"8","author":"Chankeshwara","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111601_bib51","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1021\/ol060846t","article-title":"Catalyst-free conjugated addition of thiols to \u03b1, \u03b2-unsaturated carbonyl compounds in water","volume":"8","author":"Khatik","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111601_bib52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1071\/CH08041","article-title":"Uncatalyzed synthesis of \u03b2-enamino ketones in PEG\u2013water","volume":"61","author":"Bandgar","year":"2008","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib53","first-page":"299","article-title":"Catalyst and solvent-free synthesis of \u03b2-enaminone derivatives","volume":"2","author":"Behbahani","year":"2018","journal-title":"Asian J. Green Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3565(25)26625-3","article-title":"Anti-inflammatory and antipyretic activities of indo-methacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid","volume":"141","author":"Winter","year":"1963","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111601_bib55","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1021\/jm800084s","article-title":"Synthesis, biological evaluation, and enzyme docking simulations of 1, 5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity","volume":"51","author":"Anzini","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib56","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","article-title":"Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain","volume":"91","author":"Seibert","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111601_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","article-title":"Synthetic analgesics. II. Dithienylbutenyl-and dithienylbutylamines","volume":"107","author":"Eddy","year":"1953","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111601_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A\u00a0new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2019.111601_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF00235973","article-title":"Sensitization of nociceptive cutaneous nerve fibers from the rat's tail by noxious mechanical stimulation","volume":"65","author":"Reeh","year":"1987","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111601_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0270(03)00241-3","article-title":"Optimization of the mechanical nociceptive threshold testing with the Randall\u2013Selitto assay","volume":"131","author":"Anseloni","year":"2003","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.ejmech.2019.111601_bib61","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/1811199a0","article-title":"Antioxidant determinations by the use of a stable free radical","volume":"181","author":"Blois","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111601_bib62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0092-8674(00)80043-4","article-title":"Stress pathways and heart failure","volume":"98","author":"Chien","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.111601_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/437613","article-title":"Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction","volume":"2013","author":"Rodrigo","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2019.111601_bib64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/14740338.4.6.1005","article-title":"Celecoxib and cardiovascular risks","volume":"4","author":"Brophy","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2019.111601_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.165.2.161","article-title":"The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus","volume":"165","author":"Sowers","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejmech.2019.111601_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.0909765106","article-title":"Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1","volume":"107","author":"Rimon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111601_bib67","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111601_bib68","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.111601_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","article-title":"Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation","volume":"245","author":"Jones","year":"1995","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.111601_bib70","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/ci600186b","article-title":"Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance","volume":"46","author":"Sato","year":"2006","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.111601_bib71","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/j.bmcl.2010.07.053","article-title":"The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: the first clinical candidate, Bioorg","volume":"20","author":"Wang","year":"2010","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111601_bib72","doi-asserted-by":"crossref","first-page":"16379","DOI":"10.1074\/jbc.M609883200","article-title":"Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib","volume":"282","author":"Blobaum","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib73","first-page":"2475","article-title":"An efficient microwave assisted solvent-free general route to cyclic enaminones","volume":"43B","author":"Chanda","year":"2004","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2019.111601_bib74","series-title":"Drug Discovery and Evaluation. Pharmacological Assays","first-page":"867","author":"Vogel","year":"2002"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:00:27Z","timestamp":1759327227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419307354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":73,"alternative-id":["S0223523419307354"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111601","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111601"}}